Janssen is fully committed to providing high quality products and services to healthcare professionals, patients and their families. Put simply, we always put the needs and well-being of the people we serve first.

It is important for us to understand all aspects of patients’ needs. That’s why we engage and collaborate with patient organizations, who play an important role in informing, supporting, and assisting patients. As a company, we learn from this interaction, and that helps us in the development of new treatments and in providing useful information.

It is our goal to ensure that these relationships and partnerships proceed within a principled framework of mutual respect and learning, integrity, independence, and transparency.

This framework has been described in the “Code Of Practice On Relationships Between The Pharmaceutical Industry And Patient Organisations", as developed by the European Federation Of Pharmaceutical Industry Associations (EFPIA) in collaboration with pan-European patient organizations. Our company adheres to these principles.

Its key components are the following:

• The independence of patient organizations, in terms of their political judgement, policies and activities, will be assured.
• All partnerships between patient organizations and the pharmaceutical industry will be based on mutual respect, with the views and decisions of each partner having equal value.
• The pharmaceutical industry will not request, nor will patient organizations undertake, the promotion of a particular medicine.
• The objectives and scope of any partnership will be transparent. Financial and non- financial support provided by the pharmaceutical industry will always be clearly acknowledged.
• The pharmaceutical industry welcomes broad funding of patient organizations from multiple sources.

In order to facilitate collaboration, Janssen has developed the following:

• A Review process by a multi-disciplinary committee to evaluate requests for funding or collaboration.
• Disclosure of the funding provided to patient organizations. The purpose of our disclosure of contributions is to demonstrate our ongoing commitment to transparency.

What is the nature of our collaboration with patient organizations? Janssen may interact with patient groups in the following ways:

• Support of educational programmes and conferences;
• Sponsorship of fund-raising events;
• Contributions to support programmes and services for the patient community and their care-givers;
• Contributions to support activities to help patients and care-givers advocate better treatment, services and support; and also collaborations to raise awareness about the diseases.

The following types of requests are generally not eligible for contributions:

• Scholarships to individuals;
• Direct contributions to individuals;
• Loans.

Contributions Process Statement

A multi-disciplinary committee reviews all requests. Requests should include the organization's mission statement, tax status, project/event description, description of how the funds will be used, project budget (if applicable) and annual operating budget.

Our Giving - National

For information related to your country please contact Janssen in your country.

Our Giving - International

Listed below are initiatives that span multiple countries within EMEA (Europe, Middle-East and Africa). To access the ‘Our Giving’ information click the appropriate link

Our Giving - International - 2008

Listed below are initiatives that span multiple countries within EMEA (Europe, Middle-East and Africa). To access the ‘Our Giving’ information click the appropriate link

Our Giving - International - 2007

Listed below are initiatives that span multiple countries within EMEA (Europe, Middle-East and Africa). To access the ‘Our Giving’ information click the appropriate link